237 related articles for article (PubMed ID: 28572445)
1. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.
Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA
FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445
[TBL] [Abstract][Full Text] [Related]
2. Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis.
Kalbitz M; Fattahi F; Grailer JJ; Jajou L; Malan EA; Zetoune FS; Huber-Lang M; Russell MW; Ward PA
FASEB J; 2016 Dec; 30(12):3997-4006. PubMed ID: 27543123
[TBL] [Abstract][Full Text] [Related]
3. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
[TBL] [Abstract][Full Text] [Related]
4. Role of complement C5a and histones in septic cardiomyopathy.
Fattahi F; Frydrych LM; Bian G; Kalbitz M; Herron TJ; Malan EA; Delano MJ; Ward PA
Mol Immunol; 2018 Oct; 102():32-41. PubMed ID: 29914696
[TBL] [Abstract][Full Text] [Related]
5. Complement as a Major Inducer of Harmful Events in Infectious Sepsis.
Fattahi F; Zetoune FS; Ward PA
Shock; 2020 Nov; 54(5):595-605. PubMed ID: 32187106
[TBL] [Abstract][Full Text] [Related]
6. Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro.
Kalbitz M; Fattahi F; Herron TJ; Grailer JJ; Jajou L; Lu H; Huber-Lang M; Zetoune FS; Sarma JV; Day SM; Russell MW; Jalife J; Ward PA
J Immunol; 2016 Sep; 197(6):2353-61. PubMed ID: 27521340
[TBL] [Abstract][Full Text] [Related]
7. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
Riedemann NC; Guo RF; Hollmann TJ; Gao H; Neff TA; Reuben JS; Speyer CL; Sarma JV; Wetsel RA; Zetoune FS; Ward PA
FASEB J; 2004 Feb; 18(2):370-2. PubMed ID: 14688199
[TBL] [Abstract][Full Text] [Related]
8. Complement dependency of cardiomyocyte release of mediators during sepsis.
Atefi G; Zetoune FS; Herron TJ; Jalife J; Bosmann M; Al-Aref R; Sarma JV; Ward PA
FASEB J; 2011 Jul; 25(7):2500-8. PubMed ID: 21478262
[TBL] [Abstract][Full Text] [Related]
9. Complement and sepsis-induced heart dysfunction.
Fattahi F; Ward PA
Mol Immunol; 2017 Apr; 84():57-64. PubMed ID: 27931779
[TBL] [Abstract][Full Text] [Related]
10. Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.
Russkamp NF; Ruemmler R; Roewe J; Moore BB; Ward PA; Bosmann M
FASEB J; 2015 Sep; 29(9):3762-72. PubMed ID: 25999468
[TBL] [Abstract][Full Text] [Related]
11. C5a-blockade improves burn-induced cardiac dysfunction.
Hoesel LM; Niederbichler AD; Schaefer J; Ipaktchi KR; Gao H; Rittirsch D; Pianko MJ; Vogt PM; Sarma JV; Su GL; Arbabi S; Westfall MV; Wang SC; Hemmila MR; Ward PA
J Immunol; 2007 Jun; 178(12):7902-10. PubMed ID: 17548628
[TBL] [Abstract][Full Text] [Related]
12. Complement-induced impairment of innate immunity during sepsis.
Huber-Lang MS; Younkin EM; Sarma JV; McGuire SR; Lu KT; Guo RF; Padgaonkar VA; Curnutte JT; Erickson R; Ward PA
J Immunol; 2002 Sep; 169(6):3223-31. PubMed ID: 12218141
[TBL] [Abstract][Full Text] [Related]
13. Role of extracellular histones in the cardiomyopathy of sepsis.
Kalbitz M; Grailer JJ; Fattahi F; Jajou L; Herron TJ; Campbell KF; Zetoune FS; Bosmann M; Sarma JV; Huber-Lang M; Gebhard F; Loaiza R; Valdivia HH; Jalife J; Russell MW; Ward PA
FASEB J; 2015 May; 29(5):2185-93. PubMed ID: 25681459
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a functional role of the second C5a receptor C5L2.
Gao H; Neff TA; Guo RF; Speyer CL; Sarma JV; Tomlins S; Man Y; Riedemann NC; Hoesel LM; Younkin E; Zetoune FS; Ward PA
FASEB J; 2005 Jun; 19(8):1003-5. PubMed ID: 15784721
[TBL] [Abstract][Full Text] [Related]
15. MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway.
Bosmann M; Patel VR; Russkamp NF; Pache F; Zetoune FS; Sarma JV; Ward PA
FASEB J; 2011 Dec; 25(12):4222-32. PubMed ID: 21859896
[TBL] [Abstract][Full Text] [Related]
16. Regulation of IL-8 production by complement-activated product, C5a, in vitro and in vivo during sepsis.
Wang L; Han G; Wang R; Chen G; Xu R; Xiao H; Li X; Geng S; Li Y; Li X; Wang J; Feng J; Riedemann NC; Guo R; Shen B; Li Y
Clin Immunol; 2010 Oct; 137(1):157-65. PubMed ID: 20591742
[TBL] [Abstract][Full Text] [Related]
17. Melatonin attenuates sepsis-induced cardiac dysfunction via a PI3K/Akt-dependent mechanism.
An R; Zhao L; Xi C; Li H; Shen G; Liu H; Zhang S; Sun L
Basic Res Cardiol; 2016 Jan; 111(1):8. PubMed ID: 26671026
[TBL] [Abstract][Full Text] [Related]
18. The harmful role of c5a on innate immunity in sepsis.
Ward PA
J Innate Immun; 2010; 2(5):439-45. PubMed ID: 20588003
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside-Rg1 attenuates sepsis-induced cardiac dysfunction by modulating mitochondrial damage via the P2X7 receptor-mediated Akt/GSK-3β signaling pathway.
Liu Z; Pan H; Zhang Y; Zheng Z; Xiao W; Hong X; Chen F; Peng X; Pei Y; Rong J; He J; Zou L; Wang J; Zhong J; Han X; Cao Y
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22885. PubMed ID: 34859534
[TBL] [Abstract][Full Text] [Related]
20. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
